Brief: Mithra Pharmaceuticals Says Goldman Sachs Exercised Last Call Option For Outstanding EUR 5 Million Drawdown

Mithra Pharmaceuticals SA

02/06/2022 07:05

June 2 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * GOLDMAN SACHS INTERNATIONAL ("GSI") HAS ELECTED TO
EXERCISE LAST
CALL OPTION IN RELATION TO OUTSTANDING DRAWDOWN OF EUR 5 MILLION
    * EXERCISE RESULTED IN THE ISSUANCE OF 725,300 SHARES OF THE
COMPANY
    * COMPANY HAS REGAINED ACCESS TO THE LDA CAPITAL COMMITMENT,
WHICH
IS STILL AVAILABLE FOR AN AMOUNT OF EUR 53 MILLION
    * FOLLOWING THIS CAPITAL INCREASE’S COMPLETION, MITHRA NOW
HAS
46,085,634 OUTSTANDING SHARES CARRYING VOTING RIGHTS
    * CURRENTLY CONTEMPLATING ADDITIONAL FINANCING OPTIONS
SUPPORTED
BY EXISTING AND NEW INVESTORS, COULD POTENTIALLY BE IMPLEMENTED
IN NEAR AND MEDIUM TERM
    * NEGOTIATIONS AROUND DONESTA LICENSE AND SUPPLY AGREEMENT
ARE
PROGRESSING, COMPLETION CURRENTLY ESTIMATED AT LATEST IN Q4 2022

Source text: https://bit.ly/3MbhjZS
Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))